                         SEQUENCE LISTING

<110>  Memgen, Inc. and H. Lee Moffitt Cancer Center and Research 
       Institute, Inc.
 
<120>  Replication-Enhanced Oncolytic Adenoviruses

<130>  150415.00008PCT

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  617
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CMV Promoter/Enhancer

<400>  1
acattgatta ttgactagtt attaatagta atcaattacg gggtcattag ttcatagccc       60

atatatggag ttccgcgtta cataacttac ggtaaatggc ccgcctggct gaccgcccaa      120

cgacccccgc ccattgacgt caataatgac gtatgttccc atagtaacgc caatagggac      180

tttccattga cgtcaatggg tggagtattt acggtaaact gcccacttgg cagtacatca      240

agtgtatcat atgccaagta cgccccctat tgacgtcaat gacggtaaat ggcccgcctg      300

gcattatgcc cagtacatga ccttatggga ctttcctact tggcagtaca tctacgtatt      360

agtcatcgct attaccatgg tgatgcggtt ttggcagtac atcaatgggc gtggatagcg      420

gtttgactca cggggatttc caagtctcca ccccattgac gtcaatggga gtttgttttg      480

gcaccaaaat caacgggact ttccaaaatg tcgtaacaac tccgccccat tgacgcaaat      540

gggcggtagg cgtgtacggt gggaggtcta tataagcaga gctctctggc taactagaga      600

acccactgct tactggc                                                     617


<210>  2
<211>  275
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SV40 Promoter/Enhancer

<400>  2
tgcatctcaa ttagtcagca accaggtgtg gaaagtcccc aggctcccca gcaggcagaa       60

gtatgcaaag catgcatctc aattagtcag caaccatagt cccgccccta actccgccca      120

tcccgcccct aactccgccc agttccgccc attctccgcc ccatggctga ctaatttttt      180

ttatttatgc agaggccgag gccgcctcgg cctctgagct attccagaag tagtgaggag      240

gcttttttgg aggcctaggc ttttgcaaaa agctt                                 275


